US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 28.020
  • +0.140+0.50%
Trading Oct 2 15:53 ET
822.51MMarket Cap-9533P/E (TTM)

Dianthus Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
969K
476K
334.76%6.42M
1.18M
1.17M
Operating revenue
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
--969K
--476K
334.76%6.42M
--1.18M
--1.17M
Cost of revenue
Gross profit
Operating expense
88.83%24.07M
129.42%18.72M
41.19%51M
13.02%13.41M
76.97%16.68M
12.75M
8.16M
148.06%36.12M
11.87M
9.43M
Selling and administrative expenses
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
244.73%6.74M
--2.04M
--2.21M
-General and administrative expense
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
244.73%6.74M
--2.04M
--2.21M
Research and development costs
76.24%18.07M
123.67%13.08M
11.78%32.84M
-10.68%8.78M
10.28%7.96M
--10.25M
--5.85M
133.06%29.38M
--9.83M
--7.22M
Operating profit
-88.55%-22.2M
-132.25%-17.84M
-62.17%-48.17M
-21.16%-12.96M
-90.93%-15.76M
-11.78M
-7.68M
-127.00%-29.71M
-10.69M
-8.25M
Net non-operating interest income expense
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
687K
606K
38,066.67%1.15M
640K
416K
Non-operating interest income
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
--687K
--606K
38,066.67%1.15M
--640K
--416K
Other net income (expense)
-117.65%-111K
-950.00%-126K
-272.62%-145K
19.05%-51K
-157.41%-31K
-51K
-12K
423.08%84K
-63K
54K
Gain on sale of security
-10.71%-31K
-33.33%-12K
-162.50%-85K
-60.00%-32K
-128.57%-16K
---28K
---9K
623.08%136K
---20K
--56K
Other non- operating income (expenses)
-247.83%-80K
-3,700.00%-114K
-15.38%-60K
55.81%-19K
-650.00%-15K
---23K
---3K
---52K
---43K
---2K
Income before tax
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
Income tax
Net income
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
Net income continuous Operations
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
---11.14M
---7.09M
-117.22%-28.48M
---10.12M
---7.78M
Minority interest income
Net income attributable to the parent company
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
Basic earnings per share
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
-117.22%-1.9218
-0.6827
-0.5253
Diluted earnings per share
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
-117.22%-1.9218
-0.6827
-0.5253
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K969K476K334.76%6.42M1.18M1.17M
Operating revenue 92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K--969K--476K334.76%6.42M--1.18M--1.17M
Cost of revenue
Gross profit
Operating expense 88.83%24.07M129.42%18.72M41.19%51M13.02%13.41M76.97%16.68M12.75M8.16M148.06%36.12M11.87M9.43M
Selling and administrative expenses 140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M244.73%6.74M--2.04M--2.21M
-General and administrative expense 140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M244.73%6.74M--2.04M--2.21M
Research and development costs 76.24%18.07M123.67%13.08M11.78%32.84M-10.68%8.78M10.28%7.96M--10.25M--5.85M133.06%29.38M--9.83M--7.22M
Operating profit -88.55%-22.2M-132.25%-17.84M-62.17%-48.17M-21.16%-12.96M-90.93%-15.76M-11.78M-7.68M-127.00%-29.71M-10.69M-8.25M
Net non-operating interest income expense 585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M687K606K38,066.67%1.15M640K416K
Non-operating interest income 585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M--687K--606K38,066.67%1.15M--640K--416K
Other net income (expense) -117.65%-111K-950.00%-126K-272.62%-145K19.05%-51K-157.41%-31K-51K-12K423.08%84K-63K54K
Gain on sale of security -10.71%-31K-33.33%-12K-162.50%-85K-60.00%-32K-128.57%-16K---28K---9K623.08%136K---20K--56K
Other non- operating income (expenses) -247.83%-80K-3,700.00%-114K-15.38%-60K55.81%-19K-650.00%-15K---23K---3K---52K---43K---2K
Income before tax -58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M-7.78M
Income tax
Net income -58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M-7.78M
Net income continuous Operations -58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M---11.14M---7.09M-117.22%-28.48M---10.12M---7.78M
Minority interest income
Net income attributable to the parent company -58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M-7.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M-117.22%-28.48M-10.12M-7.78M
Basic earnings per share 32.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784-117.22%-1.9218-0.6827-0.5253
Diluted earnings per share 32.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784-117.22%-1.9218-0.6827-0.5253
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data